January 2024 Annals highlights
Our focus this issue is on pediatric and adolescent asthma. The CME Review focuses on the use of biologics in pediatric asthma and its future.
What were you reading in 2023?
We’ll continue to provide members with important information via Insider – and our other publications and emails – in 2024.
2024 Final Medicare Physician Fee Schedule
CMS released its final rule updating the Medicare physician fee schedule for calendar year 2024 (Final Rule).
PBMs – how influential are they?
Many of us were shocked by the news that GlaxoSmithKline (GSK) Pharmaceuticals withdrew Flovent from the U.S. market at the end of 2023.
College State Delegate Job Description
State Delegates serve as the liaisons between local, state and regional societies; the Super Delegates in their region; and HOD leadership.
College Super Delegate Job Description
College-appointed Super Delegates serve as the conduit between delegates, regional societies and the HOD leadership.
New practice parameters published for both atopic dermatitis and anaphylaxis
Newly revised practice parameters on atopic dermatitis and anaphylaxis were published online in the Annals of Allergy, Asthma & Immunology.
Advocacy Council endorses Fee Schedule fix
Congress must pass legislation before the end of the year to prevent these cuts from taking effect on Jan. 1, 2024.
For Allergy and Asthma Sufferers, Climate Change Means Worse Symptoms and Harsher Season
Many people don’t know that allergists are experts in treating asthma, and that nasal allergies and asthma are closely linked.
2024 RVUs impact allergy
Allergists are expected to experience a -1.9% reimbursement impact due to the lower 2024 conversion factor (which takes into account the 1.25% legislative incr…